Deb Sparrow, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 250 3rd Ave W, Turtle Lake, ND 58575 Phone: 701-448-2365 |
News Archive
Scientists at the Gladstone Institutes have discovered an unusual regulator of body weight and the metabolic syndrome: a molecular mechanism more commonly associated with brain cells. Lowering levels of P75 neurotrophin receptor (NTR)-a receptor involved in neuron growth and survival-protected mice fed a high-fat diet from developing obesity, diabetes, and fatty liver disease.
NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.
Genes tell cells what to do - for example, when to repair DNA mistakes or when to die-and can be turned on or off like a light switch.
Our bodies contain far more microbial genes than human genes. And a new study suggests that just as human DNA varies from person to person, so too does the massive collection of microbial DNA in the intestine.
Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.
› Verified 3 days ago